Literature DB >> 9802280

CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer.

L Höltl, C Rieser, C Papesh, R Ramoner, G Bartsch, M Thurnher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9802280     DOI： 10.1016/s0140-6736(05)60748-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization.

Authors:  H Wang; M N Griffiths; D R Burton; P Ghazal
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate.

Authors:  R V Goddard; A G Prentice; J A Copplestone; E R Kaminski
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

3.  Stem cell factor produced by tumor cells expands myeloid-derived suppressor cells in mice.

Authors:  Wei-Chen Lee; Pao-Yueh Hsu; Hsiu-Ying Hsu
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

4.  Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial.

Authors:  Bas D Koster; Saskia J A M Santegoets; Jorien Harting; Arnold Baars; S Marieke van Ham; Rik J Scheper; Erik Hooijberg; Tanja D de Gruijl; Alfons J M van den Eertwegh
Journal:  Cancer Immunol Immunother       Date:  2019-03-09       Impact factor: 6.968

Review 5.  Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors.

Authors:  Katerina Kalkusova; Sindija Smite; Elea Darras; Pavla Taborska; Dmitry Stakheev; Luca Vannucci; Jirina Bartunkova; Daniel Smrz
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

6.  An optimized method for manufacturing a clinical scale dendritic cell-based vaccine for the treatment of glioblastoma.

Authors:  Sara Nava; Marta Dossena; Simona Pogliani; Serena Pellegatta; Carlo Antozzi; Fulvio Baggi; Cinzia Gellera; Bianca Pollo; Eugenio A Parati; Gaetano Finocchiaro; Simona Frigerio
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

7.  Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma.

Authors:  Gennadi Tulchiner; Renate Pichler; Hanno Ulmer; Nina Staudacher; Andrea Katharina Lindner; Andrea Brunner; Bettina Zelger; Fabian Steinkohl; Friedrich Aigner; Wolfgang Horninger; Martin Thurnher
Journal:  Cancer Immunol Immunother       Date:  2021-02-28       Impact factor: 6.968
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.